Selected research
Industry Research
Hereditary Disease Testing Industry Research Report 2026
Market perspective
The global Hereditary Disease Testing market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Hereditary Disease Testing market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Hereditary Disease Testing market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Hereditary Disease Testing market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Hereditary Disease Testing include Myriad Genetics, Invitae, Illumina, Natera, Laboratory Corporation of America Holdings, F. Hoffmann-La Roche, Quest Diagnostics, CooperSurgical and Agilent Technologies, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Hereditary Disease Testing market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Hereditary Disease Testing.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Hereditary Disease Testing Market by Company
Myriad Genetics
Invitae
Illumina
Natera
Laboratory Corporation of America Holdings
F. Hoffmann-La Roche
Quest Diagnostics
CooperSurgical
Agilent Technologies
Thermo Fisher Scientific
Twist Bioscience
Sophia Genetics
Fulgent Genetic
Medgenome
CENTOGENE
Hereditary Disease Testing Segment by Type
Hereditary Cancer Testing
Hereditary Non-cancer Testing
Hereditary Disease Testing Segment by Application
Hospital
Clinic
Laboratory
Others
Hereditary Disease Testing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hereditary Disease Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Hereditary Disease Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hereditary Disease Testing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Hereditary Disease Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Hereditary Cancer Testing
- Hereditary Non-cancer Testing
Applications
- Hospital
- Clinic
- Laboratory
- Others
Companies covered
- Myriad Genetics
- Invitae
- Illumina
- Natera
- Laboratory Corporation of America Holdings
- F. Hoffmann-La Roche
- Quest Diagnostics
- CooperSurgical
- Agilent Technologies
- Thermo Fisher Scientific
- Twist Bioscience
- Sophia Genetics
- Fulgent Genetic
- Medgenome
- CENTOGENE
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Hereditary Disease Testing by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Hereditary Cancer Testing
- 2.2.3 Hereditary Non-cancer Testing
- 2.3 Hereditary Disease Testing by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospital
- 2.3.3 Clinic
- 2.3.4 Laboratory
- 2.3.5 Others
- 2.4 Assumptions and Limitations
3 Hereditary Disease Testing Breakdown Data by Type
- 3.1 Global Hereditary Disease Testing Historic Market Size by Type (2021-2026)
- 3.2 Global Hereditary Disease Testing Forecasted Market Size by Type (2027-2032)
4 Hereditary Disease Testing Breakdown Data by Application
- 4.1 Global Hereditary Disease Testing Historic Market Size by Application (2021-2026)
- 4.2 Global Hereditary Disease Testing Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Hereditary Disease Testing Market Perspective (2021-2032)
- 5.2 Global Hereditary Disease Testing Growth Trends by Region
- 5.2.1 Global Hereditary Disease Testing Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Hereditary Disease Testing Historic Market Size by Region (2021-2026)
- 5.2.3 Hereditary Disease Testing Forecasted Market Size by Region (2027-2032)
- 5.3 Hereditary Disease Testing Market Dynamics
- 5.3.1 Hereditary Disease Testing Industry Trends
- 5.3.2 Hereditary Disease Testing Market Drivers
- 5.3.3 Hereditary Disease Testing Market Challenges
- 5.3.4 Hereditary Disease Testing Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Hereditary Disease Testing Players by Revenue
- 6.1.1 Global Top Hereditary Disease Testing Players by Revenue (2021-2026)
- 6.1.2 Global Hereditary Disease Testing Revenue Market Share by Players (2021-2026)
- 6.2 Global Hereditary Disease Testing Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Hereditary Disease Testing Head Office and Area Served
- 6.4 Global Hereditary Disease Testing Players, Product Type & Application
- 6.5 Global Hereditary Disease Testing Manufacturers Established Date
- 6.6 Global Hereditary Disease Testing Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Hereditary Disease Testing Market Size (2021-2032)
- 7.2 North America Hereditary Disease Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Hereditary Disease Testing Market Size by Country (2021-2026)
- 7.4 North America Hereditary Disease Testing Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Hereditary Disease Testing Market Size (2021-2032)
- 8.2 Europe Hereditary Disease Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Hereditary Disease Testing Market Size by Country (2021-2026)
- 8.4 Europe Hereditary Disease Testing Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Hereditary Disease Testing Market Size (2021-2032)
- 9.2 Asia-Pacific Hereditary Disease Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Hereditary Disease Testing Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Hereditary Disease Testing Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Hereditary Disease Testing Market Size (2021-2032)
- 10.2 South America Hereditary Disease Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Hereditary Disease Testing Market Size by Country (2021-2026)
- 10.4 South America Hereditary Disease Testing Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Hereditary Disease Testing Market Size (2021-2032)
- 11.2 Middle East & Africa Hereditary Disease Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Hereditary Disease Testing Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Hereditary Disease Testing Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Myriad Genetics
- 12.1.1 Myriad Genetics Company Information
- 12.1.2 Myriad Genetics Business Overview
- 12.1.3 Myriad Genetics Revenue in Hereditary Disease Testing Business (2021-2026)
- 12.1.4 Myriad Genetics Hereditary Disease Testing Product Portfolio
- 12.1.5 Myriad Genetics Recent Developments
- 12.2 Invitae
- 12.2.1 Invitae Company Information
- 12.2.2 Invitae Business Overview
- 12.2.3 Invitae Revenue in Hereditary Disease Testing Business (2021-2026)
- 12.2.4 Invitae Hereditary Disease Testing Product Portfolio
- 12.2.5 Invitae Recent Developments
- 12.3 Illumina
- 12.3.1 Illumina Company Information
- 12.3.2 Illumina Business Overview
- 12.3.3 Illumina Revenue in Hereditary Disease Testing Business (2021-2026)
- 12.3.4 Illumina Hereditary Disease Testing Product Portfolio
- 12.3.5 Illumina Recent Developments
- 12.4 Natera
- 12.4.1 Natera Company Information
- 12.4.2 Natera Business Overview
- 12.4.3 Natera Revenue in Hereditary Disease Testing Business (2021-2026)
- 12.4.4 Natera Hereditary Disease Testing Product Portfolio
- 12.4.5 Natera Recent Developments
- 12.5 Laboratory Corporation of America Holdings
- 12.5.1 Laboratory Corporation of America Holdings Company Information
- 12.5.2 Laboratory Corporation of America Holdings Business Overview
- 12.5.3 Laboratory Corporation of America Holdings Revenue in Hereditary Disease Testing Business (2021-2026)
- 12.5.4 Laboratory Corporation of America Holdings Hereditary Disease Testing Product Portfolio
- 12.5.5 Laboratory Corporation of America Holdings Recent Developments
- 12.6 F. Hoffmann-La Roche
- 12.6.1 F. Hoffmann-La Roche Company Information
- 12.6.2 F. Hoffmann-La Roche Business Overview
- 12.6.3 F. Hoffmann-La Roche Revenue in Hereditary Disease Testing Business (2021-2026)
- 12.6.4 F. Hoffmann-La Roche Hereditary Disease Testing Product Portfolio
- 12.6.5 F. Hoffmann-La Roche Recent Developments
- 12.7 Quest Diagnostics
- 12.7.1 Quest Diagnostics Company Information
- 12.7.2 Quest Diagnostics Business Overview
- 12.7.3 Quest Diagnostics Revenue in Hereditary Disease Testing Business (2021-2026)
- 12.7.4 Quest Diagnostics Hereditary Disease Testing Product Portfolio
- 12.7.5 Quest Diagnostics Recent Developments
- 12.8 CooperSurgical
- 12.8.1 CooperSurgical Company Information
- 12.8.2 CooperSurgical Business Overview
- 12.8.3 CooperSurgical Revenue in Hereditary Disease Testing Business (2021-2026)
- 12.8.4 CooperSurgical Hereditary Disease Testing Product Portfolio
- 12.8.5 CooperSurgical Recent Developments
- 12.9 Agilent Technologies
- 12.9.1 Agilent Technologies Company Information
- 12.9.2 Agilent Technologies Business Overview
- 12.9.3 Agilent Technologies Revenue in Hereditary Disease Testing Business (2021-2026)
- 12.9.4 Agilent Technologies Hereditary Disease Testing Product Portfolio
- 12.9.5 Agilent Technologies Recent Developments
- 12.10 Thermo Fisher Scientific
- 12.10.1 Thermo Fisher Scientific Company Information
- 12.10.2 Thermo Fisher Scientific Business Overview
- 12.10.3 Thermo Fisher Scientific Revenue in Hereditary Disease Testing Business (2021-2026)
- 12.10.4 Thermo Fisher Scientific Hereditary Disease Testing Product Portfolio
- 12.10.5 Thermo Fisher Scientific Recent Developments
- 12.11 Twist Bioscience
- 12.11.1 Twist Bioscience Company Information
- 12.11.2 Twist Bioscience Business Overview
- 12.11.3 Twist Bioscience Revenue in Hereditary Disease Testing Business (2021-2026)
- 12.11.4 Twist Bioscience Hereditary Disease Testing Product Portfolio
- 12.11.5 Twist Bioscience Recent Developments
- 12.12 Sophia Genetics
- 12.12.1 Sophia Genetics Company Information
- 12.12.2 Sophia Genetics Business Overview
- 12.12.3 Sophia Genetics Revenue in Hereditary Disease Testing Business (2021-2026)
- 12.12.4 Sophia Genetics Hereditary Disease Testing Product Portfolio
- 12.12.5 Sophia Genetics Recent Developments
- 12.13 Fulgent Genetic
- 12.13.1 Fulgent Genetic Company Information
- 12.13.2 Fulgent Genetic Business Overview
- 12.13.3 Fulgent Genetic Revenue in Hereditary Disease Testing Business (2021-2026)
- 12.13.4 Fulgent Genetic Hereditary Disease Testing Product Portfolio
- 12.13.5 Fulgent Genetic Recent Developments
- 12.14 Medgenome
- 12.14.1 Medgenome Company Information
- 12.14.2 Medgenome Business Overview
- 12.14.3 Medgenome Revenue in Hereditary Disease Testing Business (2021-2026)
- 12.14.4 Medgenome Hereditary Disease Testing Product Portfolio
- 12.14.5 Medgenome Recent Developments
- 12.15 CENTOGENE
- 12.15.1 CENTOGENE Company Information
- 12.15.2 CENTOGENE Business Overview
- 12.15.3 CENTOGENE Revenue in Hereditary Disease Testing Business (2021-2026)
- 12.15.4 CENTOGENE Hereditary Disease Testing Product Portfolio
- 12.15.5 CENTOGENE Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst